Santa Barbara County Issues Kratom Health Warning After Five Overdose Deaths in Three Years

Why it matters

Santa Barbara County health officials are linking kratom and 7-OH to a cluster of deaths in recent years — joining a growing number of California health jurisdictions issuing formal warnings. Their advisory highlights a practical gap: kratom alkaloids don't appear on standard hospital toxicology screens, making overdose identification and treatment harder for emergency physicians.

The big picture

More than 2,000 overdose deaths nationwide since 2021 have involved kratom, though most also involved other substances. Individual county-level warnings have accelerated since Los Angeles County and the California Department of Public Health moved to restrict kratom products in late 2025. Santa Barbara's advisory adds to the evidence base that concentrated 7-OH products in particular pose a distinct overdose risk even in smaller communities.

Key findings

• Santa Barbara County confirmed five overdose deaths involving kratom over the past three years, with two occurring in 2025 alone
• Most deaths involved multiple substances including alcohol, fentanyl, and prescription opioids
• 7-OH is approximately 13 times more potent than morphine and 46 times more potent than mitragynine
• Kratom alkaloids are not detectable on standard hospital drug screens and require specialized laboratory testing
• Pregnant women who use kratom risk causing severe opioid-like withdrawal symptoms in newborns
• Officials recommend carrying naloxone and urge residents to report retail kratom sales to the Sheriff's Office

What they say

"Kratom is packaged and marketed as a harmless natural supplement," said Santa Barbara County Health Officer Dr. Henning Ansorg. "Kratom carries a significant risk of dependency and overdose — particularly when consumed in concentrated forms or combined with alcohol or other drugs."

Bottom line

Santa Barbara County is the latest California jurisdiction to issue a formal kratom health warning, citing five deaths in three years and noting that concentrated 7-OH products cannot be detected on standard hospital drug screens.